13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 34 holding rows worth $162,501,039.
- Accession
- 0001104659-23-021612
- Filer
- CIK 1582844
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 34 entries on the cover page, a total value of $162,501,039 stated on the cover page (in dollars after the unit check, H1), rows summing to $162,501,039 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,849,402 | $19,622,228 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 396,500 | $11,581,765 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 217,500 | $11,246,925 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,100,000 | $11,198,000 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 33,000 | $9,176,970 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 67,500 | $8,746,650 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 324,614 | $8,261,426 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 360,500 | $7,718,305 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 290,500 | $7,558,095 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 144,500 | $6,928,775 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,015,000 | $6,364,050 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 501,500 | $6,223,615 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 950,000 | $5,567,000 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 632,500 | $5,199,150 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 115,000 | $5,125,550 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 260,000 | $5,088,200 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 500,000 | $4,125,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 255,000 | $4,016,250 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 80,000 | $3,841,600 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 243,250 | $2,364,390 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 5,100 | $1,932,033 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 41,029 | $1,664,136 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 185,000 | $1,346,800 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 154,471 | $1,343,898 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 303,396 | $1,061,886 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 153,639 | $981,753 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 93,500 | $981,750 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 669,158 | $896,672 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 420,000 | $869,400 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 6,000 | $682,800 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 9,300 | $560,325 | dollars as filed | |
| IMARA INC | 45249V107 | COM | 44,503 | $182,017 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 5,000 | $30,500 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 90,832 | $13,125 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-021612 | this filing | 2023-02-14 | acceptance time not in the bulk data set |